Business Context and Reporting Period
This Form 8-K Current Report was filed by electroCore, Inc. (ECOR) on December 8, 2023. The filing discloses a corporate governance event: the appointment of a new director to the Board of Directors.
Key Financial Metrics
This filing does not contain financial statements, revenue, profit, cash flow, margin, debt, or liquidity data. It is a disclosure of a personnel change and related compensation arrangements.
Material Changes
- Board Expansion: The Board of Directors increased its size from seven to eight members.
- New Appointment: Charles S. Theofilos, M.D., was appointed as a new Class III director. His term lasts until the 2024 annual meeting of stockholders.
- Background: Dr. Theofilos is a retired neurosurgeon and a founder/investor in several medical device companies, including electroCore, LLC (a predecessor of the Company).
Guidance, Outlook, and Compensation
Compensation Arrangements:
- Dr. Theofilos will receive the Company's standard non-employee director cash compensation.
- He was granted an inaugural equity award effective January 1, 2024, under the Non-Employee Director Compensation Policy.
- He will enter into the Company's standard indemnification agreement for directors and executive officers.
Related Party Transactions:
- Happy Holstein Management, LLC, managed by Dr. Theofilos's spouse, participated as an investor in the Company's August 2023 registered direct public offering and concurrent private placement.
- The entity purchased 453,257 shares of common stock, pre-funded warrants for 113,314 shares, and warrants for up to 283,285 shares.
Outlook and Risks: The filing does not provide updated financial guidance, management commentary on business outlook, or specific risk factors beyond the standard disclosure of the director appointment.
Investor Verification Checklist
- Verify the terms of the inaugural equity award granted to Dr. Theofilos effective January 1, 2024.
- Review the August 2023 Form 8-K regarding the registered direct public offering to confirm the full scope of the investment by Happy Holstein Management, LLC.
- Confirm the total number of outstanding shares and the impact of the new director's equity grant on dilution.
- Check the Company's most recent 10-Q or 10-K for current financial performance, as this 8-K contains no financial data.